Skip Navigation

Archive-It

Facebook iconTwitter iconWordpress icon

National Library of Medicine

Archive-It Partner Since: Mar, 2009

Organization Type: National Institutions

Organization URL: http://www.nlm.nih.gov/   

Description:

The National Library of Medicine (NLM), the world's largest medical library and a component of the National Institutes of Health, collects, preserves, and makes available to the public information about health, medicine, and the biomedical sciences. To continue fulfilling this mission, NLM is collecting and archiving related Web content, which also serves to document the histories of health and medicine. For questions about our web archiving program contact us at nlmwebcollecting@nlm.nih.gov.

Page 1 of 1 (11 Total Results)

Title: COVID-19 Real World Data (RWD) Data Elements Harmonization Project | FDA

URL: https://www.fda.gov/drugs/coronavirus-covid-19-drugs/covid-19-real-world-data-rwd-data-elements-harmonization-project

Collection: Global Health Events web archive

Description: This project aims to harmonize a list of COVID-19 data elements with several Common Data Models (CDMs) and open standards. This web page provides information about the project and a mapping table, which is a continuously evolving document intended to serve as a resource.

Loading Wayback Capture Info...

Loading video data...

Title: Assessing COVID-19-Related Symptoms in Outpatient Adult and Adolescent Subjects in Clinical Trials of Drugs and Biological Products for COVID-19 Prevention or Treatment | FDA

URL: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/assessing-covid-19-related-symptoms-outpatient-adult-and-adolescent-subjects-clinical-trials-drugs

Collection: Global Health Events web archive

Description: The FDA is issuing this 14-page guidance to provide sponsors and investigators with considerations for approaches on how common COVID-19-related symptoms can be measured and analyzed in clinical trials evaluating drugs or biological products for the prevention or treatment of COVID-19 in outpatient adult and adolescent subjects.

Loading Wayback Capture Info...

Loading video data...

Title: Development and Licensure of Vaccines to Prevent COVID-19 | FDA

URL: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/development-and-licensure-vaccines-prevent-covid-19

Collection: Global Health Events web archive

Description: This 24-page guidance was issued to assist sponsors in the clinical development and licensure of vaccines for the prevention of COVID-19, and describes the FDA's current recommendations regarding the data needed to facilitate clinical development and licensure of vaccines to prevent COVID-19.

Loading Wayback Capture Info...

Loading video data...

Title: Emergency Use Authorization for Vaccines to Prevent COVID-19 | FDA

URL: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/emergency-use-authorization-vaccines-prevent-covid-19

Collection: Global Health Events web archive

Description: The Food and Drug Administration (FDA) has issued this 18-page guidance to provide sponsors of requests for Emergency Use Authorization (EUA) for COVID-19 vaccines with recommendations regarding the data and information needed to support the issuance of an EUA for an investigational vaccine to prevent COVID-19 for the duration of the COVID-19 public health emergency.

Loading Wayback Capture Info...

Loading video data...

Title: Enforcement Policy for Face Masks and Barrier Face Coverings During the Coronavirus Disease (COVID-19) Public Health Emergency | FDA

URL: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-face-masks-and-respirators-during-coronavirus-disease-covid-19-public-health

Collection: Global Health Events web archive

Description: This 14-page guidance provides a policy to help expand the availability of general use face masks for the general public and particulate filtering facepiece respirators (including N95 respirators) for healthcare professionals during the COVID-19 pandemic.

Loading Wayback Capture Info...

Loading video data...

Title: Enforcement Policy for Modifications to FDA Cleared Molecular Influenza and RSV Tests During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency | FDA

URL: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-modifications-fda-cleared-molecular-influenza-and-rsv-tests-during-coronavirus

Collection: Global Health Events web archive

Description: This nine-page guidance was issued to provide a policy to help expand access to certain FDA-cleared molecular assays intended for detection and identification of influenza (flu) viruses, including those molecular influenza assays that also detect and identify respiratory syncytial viruses (RSV), during the influenza season and for the duration of the COVID-19 public health emergency.

Loading Wayback Capture Info...

Loading video data...

Title: Enforcement Policy for Viral Transport Media During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (Revised) | FDA

URL: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-viral-transport-media-during-coronavirus-disease-2019-covid-19-public-health

Collection: Global Health Events web archive

Description: The FDA is issuing this 12-page guidance to help facilitate the availability of devices for use in transporting certain clinical specimens, including transport media that can be used to transport certain clinical specimens for use with molecular Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) assays or antigen-detection diagnostic SARS-CoV-2 assays for the duration of the COVID-19 public health emergency.

Loading Wayback Capture Info...

Loading video data...

Title: FDA Guidance on Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency | FDA

URL: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/fda-guidance-conduct-clinical-trials-medical-products-during-covid-19-public-health-emergency

Collection: Global Health Events web archive

Description: The Food and Drug Administration (FDA) has issued this 35-page guidance, updated on September 21, 2020, to provide general considerations to assist sponsors in assuring the safety of trial participants in the conduct of clinical trials of medical products, maintaining compliance with good clinical practice (GCP), and minimizing risks to trial integrity during the COVID-19 (coronavirus) pandemic.

Loading Wayback Capture Info...

Loading video data...

Title: Institutional Review Board (IRB) Review of Individual Patient Expanded Access Requests for Investigational Drugs and Biological Products During the COVID-19 Public Health Emergency Guidance for IRBs and Clinical Investigators | FDA

URL: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/institutional-review-board-irb-review-individual-patient-expanded-access-requests-investigational

Collection: Global Health Events web archive

Description: This eight-page guidance was issued to provide recommendations regarding the key factors and procedures that institutional review boards (IRBs) should consider when reviewing expanded access submissions for individual patient access to investigational drugs for treating COVID-19.

Loading Wayback Capture Info...

Loading video data...

Title: Investigational COVID-19 Convalescent Plasma | FDA

URL: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/investigational-covid-19-convalescent-plasma

Collection: Global Health Events web archive

Description: This 17-page guidance, updated on September 2, 2020, provides recommendations to healthcare providers and investigators on the administration and study of investigational convalescent plasma collected from individuals who have recovered from COVID-19 (COVID-19 convalescent plasma) during the public health emergency. The guidance also provides recommendations to blood establishments on the collection of COVID-19 convalescent plasma.

Loading Wayback Capture Info...

Loading video data...

Title: Policy for Coronavirus Disease-2019 Tests (Revised) | FDA

URL: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/policy-coronavirus-disease-2019-tests-during-public-health-emergency-revised

Collection: Global Health Events web archive

Description: This 20-page guidance, updated on May 11, 2020, provides a policy to help accelerate the availability of novel coronavirus (COVID-19) tests developed by laboratories and commercial manufacturers for the duration of the public health emergency.

Loading Wayback Capture Info...

Loading video data...

Page 1 of 1 (11 Total Results)